[The primary evaluation of Sal-Ammoniac extract on the therapy action in mice bearing Lewis lung cancer].

Objective: To evaluate the therapy action of Sal-Ammoniac extract on Lewis lung cancer and its toxicity to immunity.
Methods: The proliferation and cell cycle of Lewis lung cancer cells were determined by MTT assay and flow cytometry respectively. The antitumor effect of Sal-Ammoniac extract was observed by tumor injected subcutaneously in mice and its toxicity to immunity was examined by clearance rate of charcoal particles and delayed type hypersensitivity.
Results: Sal-Ammoniac extract could inhibit the proliferation of Lewis lung cancer cells with S cell cycle arrest in a dose-dependent manner in vitro. Sal-Ammoniac extract solution injected in tumor for eight days had 46.7% inhibition on Lewis lung cancer, if taken orally had only 15.7% inhibition on Lewis lung cancer in mice. Sal-Ammoniac extract solution injected subcutaneously or taken orally had no effect on the clearance rate of charcoal particles and delayed type hypersensitivity in mice.
Conclusion: The antitumor action of Sal-Ammoniac extract has relation to its recipe and has no influence on immunity.